Pharmaceutical companies can no longer rely on copyright litigation tactics to prevent generic medicines entering the market
By Alexia Marinos of Gadens Lawyers, Sydney
Australian consumers, doctors, pharmacists, health professionals and generic suppliers of medicine are set to benefit as originating pharmaceutical companies can no longer use copyright of product information to delay or prevent generic medicines entering into the market. read more…
